VAC093: A Study to Assess the Experimental Malaria Vaccines R78C and RH5.1 Combined With R21/Matrix-M (a "Multi-stage" Malaria Vaccine) (clinicaltrials.gov) - Oct 22, 2026 - P1 | N=56 | Active, not recruiting | Sponsor: University of Oxford | Trial completion date: Oct 2026 ➔ Mar 2027 | Trial primary completion date: Oct 2026 ➔ Mar 2027 | Recruiting ➔ Active, not recruiting
Enrollment closed • Trial completion date • Trial primary completion date • Infectious Disease • Malaria
|